Therapeutic compliance: A prospective analysis of various factors involved in the adherence rate in type 2 diabetes

Diabetes and Metabolism

Volumn 32, Issue 6, 2006, Pages 611-616

  Bezie, Y ^a   Molina, M ^a   Hernandez, N ^a   Batista, R ^a   Niang, S ^a   Huet, D ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

Compliance; Drug therapy; Questionnaire; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENERAL HOSPITAL; HOSPITAL BED CAPACITY; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; MALE; MEDICAL INFORMATICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETERS OF MEASUREMENT AND ANALYSIS; PATIENT COMPLIANCE; QUESTIONNAIRE; VASCULAR DISEASE;

EID: 33846410736     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70316-6     Document Type: Article

References (39)

1. Dorz S, Lazzarini L, Cattelan A, Meneghetti F, Novara C, Concia E, et al. Evaluation of Adherence to Antiretroviral Therapy in Italian HIV Patients. AIDS Patient Care STDS 2003;17:33-41.
2. Volmink J, Garner P. Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ 1997;315:1403-6.
3. Mallion J, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, et al. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996;14:137-44.
4. Bruckert E, Simonetta C, Giral P. Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia. CREOLE Study Team. J Clin Epidemiol 1999;52:589-94.
5. Riesen W, Darioli R, Noll G. Lipid-lowering therapy: strategies for improving compliance. Curr Med Res Opin 2004;20:165-73.
6. Benner J, Glynn R, Mogun H, Neumann P, Weinstein M, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61.
7. Cramer J. A Systematic Review of Adherence With Medications for Diabetes. Diabetes Care 2004;27:1218-24.
8. Group UPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
9. Group DCaCTR. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
10. Dailey G, Kim M, Lian J. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res 2002;30:71-9.
11. Evans J, Donnan P, Morris A. Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes. Diabet Med 2002;19:685-8.
12. Guillausseau PJ. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab 2003;29:79-81.
13. Srinivas G, Suresh E, Jagadeesan M, Amalraj E, Datta M. Treatment-seeking behavior and compliance of diabetic patients in a rural area of south India. Ann N Y Acad Sci 2002;958:420-4.
14. Lau D, Nau D. Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals With Type 2 Diabetes. Diabetes Care 2004;27:2149-53.
15. Glasgow R. Compliance to diabetes regimens: conceptualization, complexity, and determinants. In Patient Compliance in Medical Practice and Clinical Trials. In: Cramer J, Spilker B, editors. New York: Raven Press; 1991. p. 209-224.
16. Johnson S. Methodological issues in diabetes research: measuring adherence. Diabetes Care 1992;15:1658-67.
17. McNabb W. Adherence in diabetes: can we define it and can we measure it? Diabetes Care 1997;20:215-8.
18. Haynes R, Taylor D, Sackett D, Gibson E, Bernholz C, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-64.
19. Stephenson B. Is this patient taking the treatment as prescribed? JAMA 1993;269:2779-81.
20. Cramer J. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995;49:321-7.
21. Winland-Brown J, Valiante J. Effectiveness of different medication management approaches on elders' medication adherence. Outcomes Manag Nurs Pract 2000;4:172-6.
22. McDonald H, Garg A, Haynes R. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-79.
23. Liu H, Golin C, Miller L, Hays R, Beck C, Sanandaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-77.
24. Arnsten J, Demas P, Farzadegan H, Grant R, Gourevitch M, Chang C, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis 2001;33:1417-23.
25. Dunbar-Jacob J, Mortimer-Stephens M. Treatment adherence in chronic disease. J Clin Epidemiol 2001;54(Suppl. 1):S57-S60.
26. Paes A, Bakker A, Soe-Agnie C. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-7.
27. Donnan P, MacDonald T, Morris A. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 2002;19:279-84.
28. Claxton A, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310.
29. Morningstar B, Sketris I, Kephart G, Sclar D. Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada. J Clin Pharm Ther 2002;27:213-20.
30. Melikian C, White T, Vanderplas A, Dezii C, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther 2002;24:460-7.
31. Dezii C, Kawabata H, Tran M. Effects of once daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J 2002;95:68-71.
32. Guillausseau PJ. Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus: a focus on frequency of administration. Treat Endocrinol 2005;4:167-75.
33. Miller N. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 1997;102:43-9.
34. Grant R, Devita N, Singer D, Meigs J. Polypharmacy and Medication Adherence in Patients With type 2 Diabetes. Diabetes Care 2003;26:1408-12.
35. Norris S, Lau J, Smith S, Schmid C, Engelau M. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002;25:1159-71.
36. Pladevall M, Williams K, Potts A, Divine G, Xi H, Lafata J. Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes. Diabetes Care 2004;27:2800-5.
37. Von Korff M, Gruman J, Schaefer J, Curry S, Wagner E. Collaborative management of chronic illness. Ann Intern Med 1997;127:1097-102.
38. Odegard P, Goo A, Hummel J, Williams K, Gray S. Caring for Poorly Controlled Diabetes Mellitus: a Randomized Pharmacist Intervention. Ann Pharmacother 2005;39:433-40.
39. Krapek K, King K, Warren S, George K, Caputo D, Mihelich K, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004;38:1357-62.